Analyst Ratings for CONMED (CNMD)
CNMD Rating Summary
CNMD Price Target Summary
- Highest: $40.00 (JPMorgan)
- Lowest: $39.00 (Piper Sandler)
- Average: $39.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$39.33 (+20.7%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Avg. $ Target:
$39.33 (+20.7%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2026 | Piper Sandler | Matt O\'Brien | Downgrade | Neutral (Overweight) |
39.00 (55.00) |
37.28 (32.58) |
-12.61% | Details |
| 6/12/2025 | Needham » Updated 11/6/2025 |
Mike Matson | Downgrade | Hold (Buy) |
N/A (N/A) |
56.95 (32.58) |
-42.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
